Axa
MEDP icon

Axa’s Medpace MEDP Stock Holding History

Axa’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,282
Closed -$2.91M – 656
2025
Q2 		$2.91M Hold
9,282
– – 0.01% 686
2025
Q1 		$2.83M Sell
9,282
-13,618
-59% -$4.58M 0.01% 667
2024
Q4 		$7.61M Sell
22,900
-9,858
-30% -$3.34M 0.02% 439
2024
Q3 		$10.9M Sell
32,758
-1,260
-4% -$479K 0.03% 380
2024
Q2 		$14M Buy
34,018
+3,479
+11% +$1.38M 0.04% 334
2024
Q1 		$12.3M Sell
30,539
-17,052
-36% -$6M 0.04% 373
2023
Q4 		$14.6M Buy
47,591
+11,091
+30% +$2.99M 0.05% 328
2023
Q3 		$8.84M Sell
36,500
-6,100
-14% -$1.56M 0.03% 412
2023
Q2 		$10.2M Buy
42,600
+10,700
+34% +$2.22M 0.03% 408
2023
Q1 		$6M Sell
31,900
-8,600
-21% -$1.78M 0.02% 519
2022
Q4 		$8.6M Sell
40,500
-4,100
-9% -$819K 0.03% 469
2022
Q3 		$7.01M Buy
44,600
+9,500
+27% +$1.52M 0.03% 507
2022
Q2 		$5.25M Buy
35,100
+24,800
+241% +$3.59M 0.02% 568
2022
Q1 		$1.68M Sell
10,300
-49,900
-83% -$8.23M ﹤0.01% 863
2021
Q4 		$13.1M Sell
60,200
-4,700
-7% -$984K 0.03% 435
2021
Q3 		$12.3M Buy
64,900
+48,200
+289% +$8.79M 0.03% 444
2021
Q2 		$2.95M Buy
16,700
+1,800
+12% +$311K 0.01% 810
2021
Q1 		$2.44M Hold
14,900
– – 0.01% 819
2020
Q4 		$2.07M Buy
14,900
+2,200
+17% +$277K 0.01% 847
2020
Q3 		$1.42M Hold
12,700
– – 0.01% 878
2020
Q2 		$1.18M Sell
12,700
-2,600
-17% -$221K ﹤0.01% 919
2020
Q1 		$1.12M Buy
+15,300
New +$1.33M 0.01% 835
2019
Q3 		– Sell
-14,800
Closed -$968K – 1330
2019
Q2 		$968K Sell
14,800
-10,900
-42% -$628K ﹤0.01% 981
2019
Q1 		$1.52M Sell
25,700
-29,500
-53% -$1.76M 0.01% 900
2018
Q4 		$2.92M Buy
55,200
+28,700
+108% +$1.58M 0.01% 739
2018
Q3 		$1.59M Buy
+26,500
New +$1.45M 0.01% 928

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Axa's MEDP Position: Q3 2025 in Review

Axa sold out of Medpace (MEDP) in Q3 2025, closing a stake of 9,282 shares — an estimated $2.91M sold.

Axa first reported a position in MEDP in Q3 2018 and held it in 26 quarters. The position peaked at $14.6M in Q4 2023. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Axa reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Axa sold 9,282 Medpace shares in Q3 2025, an estimated $2.91M.
  • Axa first reported a position in Medpace in Q3 2018 and held it in 26 quarters.
  • Axa's Medpace position peaked at $14.6M in Q4 2023.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.